COPD Prevalence and Mortality are High

  • Globally 3M deaths annually

  • 3rd Leading Cause of Death in the US

  • 17M patients diagnosed with COPD in the US

References:

- Global Initiative for Chronic Obstructive Lung Disease:  2024 Report;

- LEK Study, Perspectives on chronic care management, RPM, & home health, June 2024

https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-prevalence

COPD is a Significant Economic Burden*

AND … Acute exacerbations are a major source of the morbidity and mortality associated with the disease and are estimated to represent 35–60% of the total direct costs associated with COPD**

*https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-burden

** Clinical Predictors of Frequent Exacerbations in Subjects with Severe Chronic Obstructive Pulmonary Disease (COPD);

COPD Has High Mortality Rates

Later stages show less than 40% survival at 6 years

Reference: 

The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients – A Prospective Multicenter Study, Koblizek et al, International Journal of Chronic Obstructive Pulmonary Disease 2021:16 1171–1182

Earlier Intervention in COPD is the Key

Published evidence demonstrates that earlier treatment was associated with faster recovery, reduces risk of hospitalization and is associated with a better health-related quality of life.

  • Reference: Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease, Wedzicha et al, Am J Respir Crit Care Med Vol 169. pp 1298–1303, 2004